Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Functional complexity of the Leishmania granuloma and the potential of in silico modeling.

Moore JW, Moyo D, Beattie L, Andrews PS, Timmis J, Kaye PM.

Front Immunol. 2013 Feb 15;4:35. doi: 10.3389/fimmu.2013.00035. eCollection 2013.

2.

Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity.

Murray HW, Squires KE, Miralles CD, Stoeckle MY, Granger AM, Granelli-Piperno A, Bogdan C.

J Immunol. 1992 Mar 15;148(6):1858-63.

PMID:
1541824
3.

Tissue granuloma structure-function in experimental visceral leishmaniasis.

Murray HW.

Int J Exp Pathol. 2001 Oct;82(5):249-67. Review.

4.

The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani.

Rostan O, Gangneux JP, Piquet-Pellorce C, Manuel C, McKenzie AN, Guiguen C, Samson M, Robert-Gangneux F.

MBio. 2013 Sep 17;4(5):e00383-13. doi: 10.1128/mBio.00383-13.

5.

A Petri net model of granulomatous inflammation: implications for IL-10 mediated control of Leishmania donovani infection.

Albergante L, Timmis J, Beattie L, Kaye PM.

PLoS Comput Biol. 2013;9(11):e1003334. doi: 10.1371/journal.pcbi.1003334. Epub 2013 Nov 21.

6.

Effector role of blood monocytes in experimental visceral leishmaniasis.

Cervia JS, Rosen H, Murray HW.

Infect Immun. 1993 Apr;61(4):1330-3.

7.

The Schistosoma mansoni hepatic egg granuloma provides a favorable microenvironment for sustained growth of Leishmania donovani.

Hassan MF, Zhang Y, Engwerda CR, Kaye PM, Sharp H, Bickle QD.

Am J Pathol. 2006 Sep;169(3):943-53.

8.

B cell: T cell interactions occur within hepatic granulomas during experimental visceral leishmaniasis.

Moore JW, Beattie L, Dalton JE, Owens BM, Maroof A, Coles MC, Kaye PM.

PLoS One. 2012;7(3):e34143. doi: 10.1371/journal.pone.0034143. Epub 2012 Mar 30.

9.

Gamma Interferon-Regulated Chemokines in Leishmania donovani Infection in the Liver.

Murray HW, Luster AD, Zheng H, Ma X.

Infect Immun. 2016 Dec 29;85(1). pii: e00824-16. doi: 10.1128/IAI.00824-16. Print 2017 Jan.

10.

Lessons from other diseases: granulomatous inflammation in leishmaniasis.

Kaye PM, Beattie L.

Semin Immunopathol. 2016 Mar;38(2):249-60. doi: 10.1007/s00281-015-0548-7. Epub 2015 Dec 17. Review.

11.

Invariant NKT cells drive hepatic cytokinic microenvironment favoring efficient granuloma formation and early control of Leishmania donovani infection.

Robert-Gangneux F, Drogoul AS, Rostan O, Piquet-Pellorce C, Cayon J, Lisbonne M, Herbelin A, Gascan H, Guiguen C, Samson M, Gangneux JP.

PLoS One. 2012;7(3):e33413. doi: 10.1371/journal.pone.0033413. Epub 2012 Mar 22.

13.

The immunopathology of experimental visceral leishmaniasis.

Kaye PM, Svensson M, Ato M, Maroof A, Polley R, Stager S, Zubairi S, Engwerda CR.

Immunol Rev. 2004 Oct;201:239-53. Review.

PMID:
15361245
14.

Lack of CXCR3 delays the development of hepatic inflammation but does not impair resistance to Leishmania donovani.

Barbi J, Oghumu S, Rosas LE, Carlson T, Lu B, Gerard C, Lezama-Davila CM, Satoskar AR.

J Infect Dis. 2007 Jun 1;195(11):1713-7. Epub 2007 Apr 16.

PMID:
17471442
15.
16.

Defect in the tissue cellular immune response: experimental visceral leishmaniasis in euthymic C57BL/6 ep/ep mice.

Squires KE, Kirsch M, Silverstein SC, Acosta A, McElrath MJ, Murray HW.

Infect Immun. 1990 Dec;58(12):3893-8.

17.

The dynamics of granuloma formation in experimental visceral leishmaniasis.

McElrath MJ, Murray HW, Cohn ZA.

J Exp Med. 1988 Jun 1;167(6):1927-37.

18.

Involvement of CD4⁺ Foxp3⁺ regulatory T cells in persistence of Leishmania donovani in the liver of alymphoplastic aly/aly mice.

Tiwananthagorn S, Iwabuchi K, Ato M, Sakurai T, Kato H, Katakura K.

PLoS Negl Trop Dis. 2012;6(8):e1798. doi: 10.1371/journal.pntd.0001798. Epub 2012 Aug 21.

19.

Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis.

Yadav A, Amit A, Chaudhary R, Chandel AS, Mahantesh V, Suman SS, Singh SK, Dikhit MR, Ali V, Rabidas V, Pandey K, Kumar A, Das P, Bimal S.

Int J Parasitol. 2015 Jan;45(1):33-42. doi: 10.1016/j.ijpara.2014.08.013. Epub 2014 Oct 15.

PMID:
25449949
20.

Role and effect of IL-2 in experimental visceral leishmaniasis.

Murray HW, Miralles GD, Stoeckle MY, McDermott DF.

J Immunol. 1993 Jul 15;151(2):929-38.

PMID:
8335921

Supplemental Content

Support Center